Industries

---

Pharmaceutical companies operate under stringent regulatory oversight and often across multiple jurisdictions. Despite their legitimacy, financial complexity can arise from international operations, group structures, and regulated supply chains.

Paytiva advises pharmaceutical businesses on financial infrastructure aligned with regulatory expectations, institutional risk assessment, and operational scale.

Biotechnology and life sciences businesses often operate at earlier stages of development, with a strong focus on research, clinical progression, and intellectual property. These businesses typically face extended commercialisation timelines and evolving regulatory obligations.

Financial infrastructure must therefore accommodate capital-intensive operations, shifting risk profiles, and the expectations of institutional counterparties as organisations progress from research through to commercial scale.

The medicinal cannabis sector operates within evolving regulatory frameworks and remains subject to heightened scrutiny from financial institutions due to jurisdictional variation and legacy risk perceptions.

Paytiva has extensive experience advising licensed medicinal cannabis businesses across cultivation, manufacturing, distribution, and ancillary services. We understand the regulatory expectations placed on both operators and financial institutions, enabling us to advise on financial structures that are sustainable.

In addition to the sectors outlined above, Paytiva selectively advises businesses operating in other regulated or complex industries where financial access requires specialist consideration.

These engagements are assessed on a case-by-case basis to ensure alignment with regulatory standards, institutional risk appetite, and the nature of the client’s activities.